Vera Therapeutics VERA Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Vera Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's current ratio?
- Vera Therapeutics (VERA) reported current ratio of 13.6× in Q1 2026.
- How has Vera Therapeutics's current ratio changed year-over-year?
- Vera Therapeutics's current ratio decreased by 50.7% year-over-year, from 27.7× to 13.6×.
- What is the long-term trend for Vera Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Vera Therapeutics's current ratio has grown at a -9.6% compound annual growth rate (CAGR), from 22.6× to 13.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.